in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—26 February
8:07 AM MST | February 26, 2013 | Deepti Ramesh
Informex 2013: Bright outlook for US API manufacturing Drug companies looking for speedy turnaround and strong intellectual property (IP) protection for active pharmaceutical ingredient (API) production are moving away from low-cost emerging market firms, lifting prospects for US-based producers, according to attendees of Informex, at Anaheim, CA, last week. Executives said they are seeing more situations where clients feel as though the risk level to bringing the final stages of API production to Asia is too high and are bringing later-phase activities back to...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee